Trial intelligence / Profile preview

Fluticasone Furoate Nasal Spray in Perennial Allergic Rhinitis

NCT00289198Phase 3Completed

Sponsor
GSK
Start
Feb 2006
Primary completion
Jul 2006
Modality
Orthosteric Ligands
Countries
9
01

Overview

A Phase 3 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Feb 2006; status: completed.

02

Drugs

fluticasone
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00289198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00289198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call